{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:29:24Z","timestamp":1791152964690,"version":"4.1.0"},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2009,1,28]],"date-time":"2009-01-28T00:00:00Z","timestamp":1233100800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objectives: <\/jats:bold> The clinical significance of liver steatosis has been studied because steatosis plays a role in the progression of liver fibrosis. Nevertheless, the impact of steatosis in the early stage of fibrosis in non\u2010obese young men with chronic hepatitis B (CHB) is poorly understood. Thus, the purpose of this study was to investigate the prevalence of hepatic steatosis, assess the relationship between hepatic steatosis and fibrosis and to assess the laboratory parameters for predicting clinically significant liver fibrosis in non\u2010obese young men with CHB.<\/jats:p><jats:p><jats:bold>Methods: <\/jats:bold> We prospectively evaluated liver biopsies in young male patients with CHBwith a serum alanine aminotransferase level of more than two times the upper limit of normal for at least 3 months before enrollment. Patients were excluded when they had co\u2010infection with another virus and prior antiviral treatment. Demographical, anthropometric and laboratory parameters were analysed. Liver steatosis, necroinflammation and fibrosis were also assessed.<\/jats:p><jats:p><jats:bold>Results: <\/jats:bold> A total of 86 young male patients with CHB were included in this study. The median age was 21 years (range, 20\u201326 years) and the median body mass index was 23.0\u2003kg\/m<jats:sup>2<\/jats:sup> (range, 18.0\u201328.3\u2003kg\/m<jats:sup>2<\/jats:sup>). Steatosis was present in 44 patients (51.2%). Significant fibrosis (beyond periportal fibrosis) was present in 50 patients (58.1%). Steatosis was associated with insulin, homeostasis model for insulin resistance (HOMA\u2010IR), total cholesterol and triglycerides. On multiple regression analysis, steatosis was independently associated with triglyceride and HOMA\u2010IR. Significant fibrosis was independently associated with \u03b3\u2010glutamyltransferase (GGT) and necroinflammation activity. However, there was no significant association between significant fibrosis and the presence of steatosis.<\/jats:p><jats:p><jats:bold>Conclusions: <\/jats:bold> The prevalence of hepatic steatosis is a common finding in young male patients with CHB. Hepatic steatosis in CHB patients seems to be associated with insulin resistance, but it is not associated with hepatic fibrosis. GGT levels can provide useful information on the stage of CHB.<\/jats:p>","DOI":"10.1111\/j.1478-3231.2009.01976.x","type":"journal-article","created":{"date-parts":[[2009,1,28]],"date-time":"2009-01-28T15:58:17Z","timestamp":1233158297000},"page":"878-883","source":"Crossref","is-referenced-by-count":54,"title":["Hepatic steatosis and fibrosis in young men with treatment\u2010na\u00efve chronic hepatitis B"],"prefix":"10.1111","volume":"29","author":[{"given":"Jung Won","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Kyun","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Joo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Il","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Il","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Kyu","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ho","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Ho","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,6,5]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"S5","article-title":"The epidemiology of nonalcoholic fatty liver disease in adults","volume":"40","author":"Clark JM.","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"e_1_2_6_3_2","first-page":"778","article-title":"Non\u2010alcoholic fatty liver disease in the Asia\u2010Pacific region","volume":"22","author":"Chitturi S","year":"2007","journal-title":"definitions and overview of proposed guidelines"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70590-6"},{"key":"e_1_2_6_5_2","first-page":"729","article-title":"Steatosis in chronic hepatitis C","volume":"36","author":"Monto A","year":"2002","journal-title":"relative contributions of obesity, diabetes mellitus, and alcohol"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2002.02813.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00299-4"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50267"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00456-9"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199512000-00007"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.04857.x"},{"key":"e_1_2_6_12_2","first-page":"337","article-title":"Histological grading and staging of chronic hepatitis standardized guideline proposed by the Korean Study Group for the Pathology of Digestive Diseases","volume":"33","author":"Park YN","year":"1999","journal-title":"Korean J Pathol"},{"key":"e_1_2_6_13_2","first-page":"2467","article-title":"Nonalcoholic steatohepatitis","volume":"94","author":"Brunt EM","year":"1999","journal-title":"a proposal for grading and staging the histological lesions"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20519"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.24432"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36572"},{"key":"e_1_2_6_17_2","first-page":"5","article-title":"Steatosis","volume":"42","author":"Powell EE","year":"2005","journal-title":"co-factor in other liver diseases"},{"key":"e_1_2_6_18_2","first-page":"233","article-title":"Prevalence of liver steatosis in patients with chronic hepatitis B","volume":"18","author":"Thomopoulos KC","year":"2006","journal-title":"a study of associated factors and of relationship with fibrosis"},{"key":"e_1_2_6_19_2","first-page":"38","article-title":"Hepatic steatosis in chronic hepatitis B and C","volume":"43","author":"Gordon A","year":"2005","journal-title":"predictors, distribution and effect on fibrosis"},{"key":"e_1_2_6_20_2","first-page":"936","article-title":"Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors","volume":"39","author":"Tsochatzis E","year":"2007","journal-title":"a comparative approach with genotype 1 chronic hepatitis C"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2007.01482.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)00271-5"},{"key":"e_1_2_6_23_2","first-page":"3000","article-title":"Nonalcoholic fatty liver disease","volume":"289","author":"Clark JM","year":"2003","journal-title":"an underrecognized cause of cryptogenic cirrhosis"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300109"},{"key":"e_1_2_6_25_2","first-page":"687","article-title":"Factors predictive of liver cirrhosis in patients with chronic hepatitis B","volume":"12","author":"Huo T","year":"2000","journal-title":"a multivariate analysis in a longitudinal study"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41289.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20960"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i4.525"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200604000-00012"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1478-3231.2009.01976.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1478-3231.2009.01976.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T18:19:00Z","timestamp":1697134740000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1478-3231.2009.01976.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,5]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1111\/j.1478-3231.2009.01976.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1478-3231.2009.01976.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,5]]}}}